TriVascular Technologies, Inc. (TRIV)

[PerserNL]

TRIV huge potential and price-target +100%, read this:


Stock Price Target

Sell-side firms covering the company, have a 12-month price target of $10.333 on the stock. This is according to the 3 analysts polled by Zacks which are taken into account to arrive at the average. The most positive analyst view sees the stock reaching $13. On the other hand, the most conservative analyst report has a $9 price target on the name.

Zacks compiles analyst recommendations into a simplified scale due to the complexity of the various methods and terminology of research firms. The scale provides an Average Broker Rating based on a 1 to 5 sliding scale where 1 signifies a Strong Buy and 5 a Strong Sell recommendation. TriVascular Technologies, Inc. currently has an average broker rating of 1. The stock had a rating of 1 three months ago.

http://www.investornewswire.com/analyst-views/quarterly-earnings-watch-trivascular-technologies-inc-nasdaqtriv/44790/